Literature DB >> 32476839

Sarcoidosis as a risk factor for venous thromboembolism.

Anna Goljan Geremek1, Witold Tomkowski2, Marcin Geremek3, Elżbieta Puścińska1, Grzegorz Małek4, Adam Nowiński1, Michal Bednarek1, Paweł Śliwiński1.   

Abstract

Sarcoidosis as a chronic condition of immune dysregulation might be associated with increased risk of venous thromboembolism (VTE). In this study we report three cases of sarcoidosis and pulmonary embolism (PE) occurring together, that share common clinical, serological and pathological findings, confirming the diagnosis of active pulmonary sarcoidosis and no others co-existing prothrombotic factors. We hypothesized that the hypercoagulability and increased risk for VTE in sarcoidosis may be attributable to active local and generalized inflammatory process. The possible relation of clinical picture of sarcoidosis that favors thrombus formation and the bidirectional inflammation and coagulation process are discussed. Further investigation of PE in patients with sarcoidosis are required as the co-incidence of both diseases seems to be more frequent than expected. (Sarcoidosis Vasc Diffuse Lung Dis 2017; 34: 170-178). Copyright:
© 2017.

Entities:  

Keywords:  inflammation; pulmonary embolism; sarcoidosis

Year:  2017        PMID: 32476839      PMCID: PMC7170146          DOI: 10.36141/svdld.v34i2.4911

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  37 in total

1.  Sarcoidosis presenting as upper extremity venous thrombosis.

Authors:  A M McLaughlin; W T McNicholas
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

2.  [Thoracic venous thrombosis in the course of sarcoidosis].

Authors:  K Marc; J E Bourkadi; J Benamor; G Iraqi
Journal:  Rev Mal Respir       Date:  2008-01       Impact factor: 0.622

Review 3.  Sarcoidosis: clinical update.

Authors:  U Costabel
Journal:  Eur Respir J Suppl       Date:  2001-09

4.  Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients.

Authors:  E Neville; A N Walker; D G James
Journal:  Q J Med       Date:  1983

5.  Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases.

Authors:  J Mañá; A Salazar; F Manresa
Journal:  Respiration       Date:  1994       Impact factor: 3.580

6.  Meningeal sarcoidosis causing intracranial hypertension secondary to dural sinus thrombosis.

Authors:  J V Byrne; C A Lawton
Journal:  Br J Radiol       Date:  1983-10       Impact factor: 3.039

7.  D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients.

Authors:  Andrew F Shorr; Stephen J Thomas; Stephan A Alkins; Thomas M Fitzpatrick; Geoffrey S Ling
Journal:  Chest       Date:  2002-04       Impact factor: 9.410

8.  Circulating D dimer in patients with sarcoidosis.

Authors:  A F Shorr; O W Hnatiuk
Journal:  Chest       Date:  2000-04       Impact factor: 9.410

9.  Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.

Authors:  Scott E Musicant; Lloyd M Taylor; Dawn Peters; Robert A Schuff; Rakhee Urankar; Gregory J Landry; Gregory L Moneta
Journal:  J Vasc Surg       Date:  2006-04       Impact factor: 4.268

10.  Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis.

Authors:  J D Hasday; P R Bachwich; J P Lynch; R G Sitrin
Journal:  Exp Lung Res       Date:  1988       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.